Kymera Therapeutics, Inc. · NASDAQ:KYMR

Jacobs Bruce N. sold 77,109 Kymera Therapeutics, Inc. shares (Form 4)

Traded Jun 30, 2026 · Filed Jul 2, 2026

On Jun 30, 2026, Jacobs Bruce N. (Chief Financial Officer) sold 77,109 Kymera Therapeutics, Inc. shares at an average US$114.97 for US$8.86M under a trading plan, leaving 244,883 shares. Filed Jul 2, 2026 (Form 4).

Sold
77,109 shares
Price
US$114.97 average (US$110.54 to US$117.70)
Value
US$8.86M
Holding after
244,883 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Common StockOption exercise61,378US$5.33321,992Direct
Jun 30, 2026Common StockSale1,500US$110.54320,492Direct
Jun 30, 2026Common StockSale1,700US$111.57318,792Direct
Jun 30, 2026Common StockSale1,100US$112.79317,692Direct
Jun 30, 2026Common StockSale4,110US$114.19313,582Direct
Jun 30, 2026Common StockSale51,375US$114.77262,207Direct
Jun 30, 2026Common StockSale7,971US$115.82254,236Direct
Jun 30, 2026Common StockSale6,153US$116.99248,083Direct
Jun 30, 2026Common StockSale3,200US$117.70244,883Direct

Source

View original at SEC

Related